Risk of malignancy in patients with psoriasis receiving systemic medications: A nested case-control study.
Dermatol Ther
; 35(11): e15804, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-36068977
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Psoriasis
/
Biological Products
/
Dermatologic Agents
/
Neoplasms
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Year:
2022
Type:
Article